MichelleRengarajanMD
Internal Medicine • Boston, MAEndocrinology
Fellow at Massachusetts General Hospital
Dr. Rengarajan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-726-3872Fax+1 617-726-5905
Education & Training
Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2018 - 2022
Brigham and Women's HospitalResidency, Internal Medicine, 2016 - 2018
Stanford University School of MedicineClass of 2016
Certifications & Licensure
MA State Medical License 2016 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 25 citationsAdhesion to the host cell surface is sufficient to mediate Listeria monocytogenes entry into epithelial cellsFabian E. Ortega, Michelle Rengarajan, Natalie Chavez, Prathima Radhakrishnan, Martijn Gloerich
Molecular Biology of the Cell. 2017-11-01 - 142 citationsHuman Myo19 Is a Novel Myosin that Associates with MitochondriaOmar A. Quintero, Melinda M. DiVito, Rebecca C. Adikes, Melisa B. Kortan, Audun Lier
Current Biology. 2009-12-15 - 109 citationsNematodes, bacteria, and flies: a tripartite model for nematode parasitism.Elissa A. Hallem, Michelle Rengarajan, Todd A. Ciche, Paul W. Sternberg
Current Biology. 2007-05-15
Press Mentions
Identification of Immune Checkpoint Inhibitor–Induced DiabetesAugust 29th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
